Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Australia shares end down, commodities drag; NZ finishes at record

Published 05/06/2018, 05:13 pm
Updated 05/06/2018, 05:20 pm
© Reuters.  Australia shares end down, commodities drag; NZ finishes at record
AXJO
-
C
-
DBKGn
-
BHP
-
CSL
-
CBA
-
ANZ
-
RIO
-
BHPB
-
MGR
-
ORG
-
RHC
-
RIO
-
WDS
-
AXHJ
-
NKTR
-

* Commodity stocks lead losses, banks rise as CBA extends gains

* ACCC lays criminal cartel charges against ANZ

* Retail property manager Mirvac falls on UBS rate downgrade

* NZ closes at record, a2 Milk Company top support (Updates to close)

By Devika Syamnath

June 5 (Reuters) - Australian shares ended on a dour note on Tuesday as losses in commodity stocks outweighed a relief rally for banks after Commonwealth settled a civil lawsuit filed by financial intelligence agency AUSTRAC.

The S&P/ASX 200 index .AXJO closed 0.5 percent lower, or 30.6 points at 5,994.9. The benchmark rose 0.6 percent on Monday.

Australia's central bank left interest rates unchanged at record lows as expected, flagging lukewarm inflation and wage growth. stocks declined on weak metal prices, notably iron ore, while a sharp overnight fall in global oil prices hurt energy shares. MET/L IRONORE/ O/R

Global mining heavyweights Rio Tinto (LON:RIO) RIO.AX and BHP Billiton (LON:BLT) BHP.AX both fell 1.4 percent.

Gas supplier Origin Energy ORG.AX lost 2.4 percent, while Woodside Petroleum WPL.AX shed 0.7 percent.

Real estate stocks were under pressure with Mirvac Group MGR.AX falling 3.5 percent after UBS downgraded the stock, citing weaker home prices, said Damian Rooney, director of equity sales at Argonaut.

Credit tightening could impact "Mirvac's best customer, the investor, and best market, Sydney," said UBS in a note.

Home prices across Australia's major cities eased for an eighth straight month in May as tighter lending standards at banks cooled demand in Sydney and Melbourne. healthcare stocks .AXHJ pulled back from a record high on Monday. CSL Ltd CSL.AX dropped 0.9 percent and Ramsay Health Care RHC.AX slid 3 percent to its lowest close in over two years.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Rooney said U.S. based drug developer Nektar Therapeutics' NKTR.O overnight tumble sapped confidence in Australian pharma stocks. Nektar's shares tanked nearly 42 percent after data from trials testing its experimental cancer drug with Bristol-Myers Squibb's Opdivo disappointed investors. just reminds people that being involved with new discoveries can be fairly difficult," said Rooney.

On the other hand, financials held up as CBA CBA.AX extended gains and rose 1 percent despite being slapped with a record penalty to settle money laundering charges by AUSTRAC on Monday. after markets closed, Australia's competition watchdog charged Australia and New Zealand Bank ANZ.AX , along with units of Citigroup (NYSE:C) and Deutsche Bank (DE:DBKGn), with criminal cartel charges. Zealand's benchmark S&P/NZX 50 index .NZ50 climbed 1.4 percent or 120.88 points, to a record closinhg high of 8,757.0.

The index enjoyed broad gains led by dairy producer A2 Milk Company ATM.NZ , which added 5.3 percent.

Peer Fonterra Co-Operative Group FCG.NZ rose about 1 percent after it said total domestic milk production in April rose 3 percent.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.